JP2012527485A - Ｐｒｇ４及びその治療調節作用の応用及び使用 - Google Patents

Ｐｒｇ４及びその治療調節作用の応用及び使用 Download PDF

Info

Publication number
JP2012527485A
JP2012527485A JP2012512085A JP2012512085A JP2012527485A JP 2012527485 A JP2012527485 A JP 2012527485A JP 2012512085 A JP2012512085 A JP 2012512085A JP 2012512085 A JP2012512085 A JP 2012512085A JP 2012527485 A JP2012527485 A JP 2012527485A
Authority
JP
Japan
Prior art keywords
prg4
composition
oral
oil
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012512085A
Other languages
English (en)
Japanese (ja)
Inventor
サリバン，ベンジャミン
シュミット，タンニン
トルイト，エドワード，アール．
トルイト，ニコル，バーバラ，ジャスティス
サリバン，デヴィッド
Original Assignee
ルブリス，エルエルシー．
シェペンズ アイ リサーチ インスティテュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ルブリス，エルエルシー．, シェペンズ アイ リサーチ インスティテュート filed Critical ルブリス，エルエルシー．
Publication of JP2012527485A publication Critical patent/JP2012527485A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
JP2012512085A 2009-05-22 2010-05-24 Ｐｒｇ４及びその治療調節作用の応用及び使用 Pending JP2012527485A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18052509P 2009-05-22 2009-05-22
US61/180,525 2009-05-22
PCT/US2010/035956 WO2010135736A2 (en) 2009-05-22 2010-05-24 Application and uses of prg4 and therapeutic modulation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014241399A Division JP6159704B2 (ja) 2009-05-22 2014-11-28 Ｐｒｇ４及びその治療調節作用の応用及び使用

Publications (1)

Publication Number Publication Date
JP2012527485A true JP2012527485A (ja) 2012-11-08

Family

ID=43126811

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012512085A Pending JP2012527485A (ja) 2009-05-22 2010-05-24 Ｐｒｇ４及びその治療調節作用の応用及び使用
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Ｐｒｇ４及びその治療調節作用の応用及び使用
JP2017004063A Expired - Fee Related JP6483164B2 (ja) 2009-05-22 2017-01-13 Ｐｒｇ４及びその治療調節作用の応用及び使用
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Ｐｒｇ４及びその治療調節作用の応用及び使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Ｐｒｇ４及びその治療調節作用の応用及び使用
JP2017004063A Expired - Fee Related JP6483164B2 (ja) 2009-05-22 2017-01-13 Ｐｒｇ４及びその治療調節作用の応用及び使用
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Ｐｒｇ４及びその治療調節作用の応用及び使用

Country Status (7)

Country Link
US (2) US9730865B2 (enExample)
EP (1) EP2432492B1 (enExample)
JP (4) JP2012527485A (enExample)
CN (1) CN102711796A (enExample)
CA (2) CA3110817C (enExample)
ES (1) ES2532526T3 (enExample)
WO (1) WO2010135736A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016539189A (ja) * 2013-11-26 2016-12-15 ルブリス，エルエルシー． 細胞間相互作用を阻害するための組成物及び方法
JP2021050147A (ja) * 2019-09-24 2021-04-01 日油株式会社 デンタルプラーク・ステイン付着防止剤および口腔用組成物
WO2025079625A1 (ja) * 2023-10-10 2025-04-17 ファイン・バイオメディカル有限会社 循環液及び潤滑性調整剤

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3110817C (en) 2009-05-22 2023-08-15 Lubris, Llc Application and uses of prg4 and therapeutic modulation thereof
WO2011091000A2 (en) * 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
EP2896429B1 (en) * 2014-01-20 2018-07-18 COR S.a.r.l. Skin Protector
MA53108A (fr) * 2015-01-26 2021-05-12 Lubris Llc Utilisation de prg4 comme agent anti-inflammatoire
DK3300482T3 (da) 2015-05-19 2021-10-18 Lubris Llc Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer
DK3313383T3 (da) * 2015-06-23 2022-12-12 Fertin Pharma As Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling
CN105055949A (zh) * 2015-08-10 2015-11-18 孙霞 一种治疗小儿口腔溃疡的中药
CN108157358A (zh) * 2018-03-02 2018-06-15 沈阳汇翼宁消毒科技有限公司 一种消毒液及其制备方法
MX2020013869A (es) * 2018-06-21 2021-03-02 Lubris Llc Lubricina para uso en curacion de heridas referencia cruzada con solicitudes relacionadas.
US20220008518A1 (en) * 2018-11-08 2022-01-13 The Schepens Eye Research Institute, Inc. Therapeutic approaches for tissue reconstruction and wound healing treatment
WO2020136620A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
JP7288090B2 (ja) 2019-06-14 2023-06-06 ザ プロクター アンド ギャンブル カンパニー 洗い流さない口腔ケア組成物
WO2020248239A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
JP2022538521A (ja) 2019-06-14 2022-09-05 ザ プロクター アンド ギャンブル カンパニー 洗い流さない口腔ケア組成物
MX2021015126A (es) 2019-06-14 2022-01-24 Procter & Gamble Composiciones para el cuidado bucal para usar y no enjuagar.
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
CN111944595B (zh) * 2020-08-21 2022-08-09 健尔康医疗科技股份有限公司 一种医用外科器械用润滑剂及其制备和使用方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938963A (en) * 1988-11-22 1990-07-03 Parnell Pharmaceuticals, Inc. Method and composition for treating xerostomia
JP2003500022A (ja) * 1999-04-23 2003-01-07 ロード アイランド ホスピタル， ア ライフスパン パートナー トリボネクチン
JP2007502122A (ja) * 2003-08-14 2007-02-08 ワイス 組換えルブリシン分子およびその使用
JP2008508338A (ja) * 2004-08-02 2008-03-21 グラクソ グループ リミテッド 口腔乾燥症用新規組成物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002977A1 (en) * 1980-04-25 1981-10-29 Orthana Kemisk Fab As Sterilized,preserved,stable mucine-containing solutions and sterilization method
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
GB2361870A (en) * 2000-05-03 2001-11-07 Zia Hashmi Treating xerostomia
EP1347993A2 (en) 2000-12-29 2003-10-01 Glaxo Group Limited Superficial zone protein and methods of making and using same
US7071228B2 (en) * 2002-10-23 2006-07-04 Parks L Dean Method of treating musculoskeletal and connective tissue inflammations
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
WO2005000331A2 (en) 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
US20070275032A1 (en) 2004-03-05 2007-11-29 Synthes (U.S.A.) Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
US8034796B2 (en) * 2004-04-07 2011-10-11 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
US20090155200A1 (en) 2004-04-20 2009-06-18 Jay Gregory D Methods of promoting cartilage healing or cartilage integration
JP2008507553A (ja) 2004-07-23 2008-03-13 ミューコサル セラピューティクス リミテッド ライアビリディ カンパニー 粘性補給のための組成物および方法
EP1827478A4 (en) 2004-12-03 2009-08-05 Mucosal Therapeutics Llc METHODS OF TREATING JOINED OR SICK JOINTS
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
SI2915529T1 (sl) 2008-05-07 2017-09-29 The Regents Of The University Of California Terapevtska regeneracija in obogatitev lubrikacije okularne površine
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
KR20110117647A (ko) * 2008-12-19 2011-10-27 카우텍스 텍스트론 씨브이에스 리미티드 차량용 유체 히터
CN102438645A (zh) 2009-01-13 2012-05-02 卢布里斯有限责任公司 阴道上皮界面润滑的治疗调节
CA3110817C (en) 2009-05-22 2023-08-15 Lubris, Llc Application and uses of prg4 and therapeutic modulation thereof
CA2771110C (en) 2009-08-13 2019-02-26 Singularis, Inc. Prg4 treatment for interstitial cystitis
WO2011091000A2 (en) 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938963A (en) * 1988-11-22 1990-07-03 Parnell Pharmaceuticals, Inc. Method and composition for treating xerostomia
JP2003500022A (ja) * 1999-04-23 2003-01-07 ロード アイランド ホスピタル， ア ライフスパン パートナー トリボネクチン
JP2007502122A (ja) * 2003-08-14 2007-02-08 ワイス 組換えルブリシン分子およびその使用
JP2008508338A (ja) * 2004-08-02 2008-03-21 グラクソ グループ リミテッド 口腔乾燥症用新規組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INT J ORAL SURG, VOL.3, P.435-439 (1974), JPN6013051906, ISSN: 0002665531 *
JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, VOL.19, P.677-687, JPN6010022996, ISSN: 0002665532 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016539189A (ja) * 2013-11-26 2016-12-15 ルブリス，エルエルシー． 細胞間相互作用を阻害するための組成物及び方法
JP2019189657A (ja) * 2013-11-26 2019-10-31 ルブリス，エルエルシー． 細胞間相互作用を阻害するための組成物及び方法
JP2021050147A (ja) * 2019-09-24 2021-04-01 日油株式会社 デンタルプラーク・ステイン付着防止剤および口腔用組成物
JP7272214B2 (ja) 2019-09-24 2023-05-12 日油株式会社 デンタルプラーク・ステイン付着防止剤および口腔用組成物
WO2025079625A1 (ja) * 2023-10-10 2025-04-17 ファイン・バイオメディカル有限会社 循環液及び潤滑性調整剤
JPWO2025079625A1 (enExample) * 2023-10-10 2025-04-17

Also Published As

Publication number Publication date
EP2432492B1 (en) 2014-12-24
US9730865B2 (en) 2017-08-15
JP6483164B2 (ja) 2019-03-13
EP2432492A2 (en) 2012-03-28
JP2015129115A (ja) 2015-07-16
US20180153776A1 (en) 2018-06-07
CA3110817C (en) 2023-08-15
CA2762989A1 (en) 2010-11-25
WO2010135736A3 (en) 2011-04-28
JP2019048824A (ja) 2019-03-28
JP2017105790A (ja) 2017-06-15
CN102711796A (zh) 2012-10-03
JP6159704B2 (ja) 2017-07-05
CA2762989C (en) 2021-04-13
US20120134925A1 (en) 2012-05-31
US10383796B2 (en) 2019-08-20
WO2010135736A2 (en) 2010-11-25
CA3110817A1 (en) 2010-11-25
ES2532526T3 (es) 2015-03-27
EP2432492A4 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
JP6483164B2 (ja) Ｐｒｇ４及びその治療調節作用の応用及び使用
WO2019025599A1 (en) GEL COMPRISING CHLORHEXIDINE
AU2011331901B2 (en) Anti-inflammatory compositions
CN104666112B (zh) 一种生物活性透明质酸牙膏
JP2022093452A (ja) 口腔用組成物
KR101821842B1 (ko) Ｐｇａ를 포함하는 새로운 ｅｍｄ 제제
US20240358743A1 (en) Cosmetic/dermatological composition
WO2000056344A1 (fr) Salive artificielle
JP2000103743A (ja) チオレドキシン活性を有するファミリーに属するポリペプチド類を含有する食品、化粧品及び医薬
EA010945B1 (ru) Применение биосовместимого полимера для изготовления медицинского устройства
JP6026717B2 (ja) ヒアルロン酸産生促進剤
CN107446018A (zh) 促进伤口愈合的肽及其应用
JP4909809B2 (ja) 人工唾液
JP6522286B2 (ja) ヒアルロン酸産生促進剤
EP3914258B1 (en) A composition for the treatment of periodontitis and regeneration of interdental papilla
JP5955631B2 (ja) ヒアルロン酸産生促進剤
JP4804420B2 (ja) 人工唾液
CN115279457A (zh) 作为对抗牙周炎或牙龈炎的活性物质的胶原蛋白水解物
EA048438B1 (ru) Применение фармацевтической композиции для лечения заболеваний и/или патологий тканей

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131029

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140128

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140228

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140729